{"Drugs":{"Drug":{"Id":22639,"DrugType":{"Type":"Biological therapeutic"},"DrugTargetMaturity":{"TargetIndication":[{"IndicationId":188,"IndicationName":"Inflammatory disease","MinPatentApplicationDate":"2003-10-03T00:00:00Z","TargetId":"PTGT-01192","TargetName":"Kallikrein"},{"IndicationId":156,"IndicationName":"Hereditary angioedema","MinPatentApplicationDate":"2014-01-17T00:00:00Z","TargetId":"PTGT-01192","TargetName":"Kallikrein"},{"IndicationId":188,"IndicationName":"Inflammatory disease","MinPatentApplicationDate":"2013-10-25T00:00:00Z","TargetId":"PTGT-03894","TargetName":"Complement C1s subcomponent"},{"IndicationId":57,"IndicationName":"Cardiovascular disease","MinPatentApplicationDate":"2013-10-25T00:00:00Z","TargetId":"PTGT-03894","TargetName":"Complement C1s subcomponent"},{"IndicationId":188,"IndicationName":"Inflammatory disease","MinPatentApplicationDate":"2010-11-16T00:00:00Z","TargetId":"PTGT-02904","TargetName":"Mannan-binding lectin serine protease"},{"IndicationId":3108,"IndicationName":"Renal injury","MinPatentApplicationDate":"2018-09-14T00:00:00Z","TargetId":"PTGT-03894","TargetName":"Complement C1s subcomponent"},{"IndicationId":250,"IndicationName":"Pancreatitis","MinPatentApplicationDate":"1996-08-14T00:00:00Z","TargetId":"PTGT-01192","TargetName":"Kallikrein"},{"IndicationId":65,"IndicationName":"Stroke","MinPatentApplicationDate":"2008-12-09T00:00:00Z","TargetId":"PTGT-03894","TargetName":"Complement C1s subcomponent"},{"IndicationId":1024,"IndicationName":"Reperfusion injury","MinPatentApplicationDate":"2014-03-07T00:00:00Z","TargetId":"PTGT-03894","TargetName":"Complement C1s subcomponent"},{"IndicationId":2989,"IndicationName":"Kidney transplant rejection","MinPatentApplicationDate":"2014-11-21T00:00:00Z","TargetId":"PTGT-03894","TargetName":"Complement C1s subcomponent"},{"IndicationId":57,"IndicationName":"Cardiovascular disease","MinPatentApplicationDate":"1998-09-11T00:00:00Z","TargetId":"PTGT-01192","TargetName":"Kallikrein"},{"IndicationId":156,"IndicationName":"Hereditary angioedema","MinPatentApplicationDate":"1994-07-28T00:00:00Z","TargetId":"PTGT-03894","TargetName":"Complement C1s subcomponent"}]},"DevelopmentStatusCurrent":{"Row":[{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"AR","$":"Argentina"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"CO","$":"Colombia"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"CR","$":"Costa Rica"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"DO","$":"Dominican Republic"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"PA","$":"Panama"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"VE","$":"Venezuela"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"1068926","$":"Hyupjin Corp"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-04-26T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1755864"}},{"Company":{"@id":"26786","$":"MegaPharm Ltd"},"Country":{"@id":"IL","$":"Israel"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-12-31T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1696842"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"DZ","$":"Algeria"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"AD","$":"Andorra"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"AT","$":"Austria"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"BH","$":"Bahrain"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"BE","$":"Belgium"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"FR","$":"France"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"DE","$":"Germany"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"IE","$":"Ireland"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"JO","$":"Jordan"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"KW","$":"Kuwait"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"LB","$":"Lebanon"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"LU","$":"Luxembourg"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"MA","$":"Morocco"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"OM","$":"Oman"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"PT","$":"Portugal"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"QA","$":"Qatar"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"ES","$":"Spain"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"CH","$":"Switzerland"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"SY","$":"Syria"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"TN","$":"Tunisia"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"GB","$":"UK"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-12-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884314"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"AE","$":"United Arab Emirates"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"YE","$":"Yemen"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"AZ","$":"Azerbaijan"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"BY","$":"Belarus"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"DK","$":"Denmark"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-12-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1158029"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"EU","$":"EU"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-12-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1158029"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"GE","$":"Georgia"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"IS","$":"Iceland"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-04-26T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1755864"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"KZ","$":"Kazakhstan"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"LV","$":"Latvia"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-08-31T00:00:00Z","SourceLink":{"@type":"PR","@id":"1218545"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"LI","$":"Liechtenstein"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-04-26T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1755864"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"NO","$":"Norway"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-12-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1158029"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"RU","$":"Russian Federation"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"RS","$":"Serbia"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"SE","$":"Sweden"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-08-31T00:00:00Z","SourceLink":{"@type":"PR","@id":"1218545"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"UA","$":"Ukraine"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-11-27T00:00:00Z","SourceLink":{"@type":"PR","@id":"1985443"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"TR","$":"Turkey"},"DevelopmentStatus":{"@id":"PR","@sortorder":"13","$":"Pre-registration"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-03-18T00:00:00Z","SourceLink":{"@type":"PR","@id":"1083845"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"CH","$":"Switzerland"},"DevelopmentStatus":{"@id":"C2","@sortorder":"11","$":"Phase 2 Clinical"},"Indication":{"@id":"3108","$":"Renal injury"},"StatusDate":"2017-01-18T00:00:00Z","SourceLink":{"@type":"TRIALREG","@id":"1912341"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C1","@sortorder":"10","$":"Phase 1 Clinical"},"Indication":{"@id":"250","$":"Pancreatitis"},"StatusDate":"2016-12-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884314"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"CU","@sortorder":"9","$":"Clinical"},"Indication":{"@id":"1259","$":"Pre-eclampsia"},"StatusDate":"2019-06-11T00:00:00Z","SourceLink":{"@type":"PR","@id":"2161502"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"CU","@sortorder":"9","$":"Clinical"},"Indication":{"@id":"1024","$":"Reperfusion injury"},"StatusDate":"2018-07-26T00:00:00Z","SourceLink":{"@type":"PR","@id":"2057258"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"AU","$":"Australia"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"1259","$":"Pre-eclampsia"},"StatusDate":"2018-10-17T00:00:00Z","SourceLink":{"@type":"PR","@id":"2116590"}},{"Company":{"@id":"1068054","$":"Transmedic Pte Ltd"},"Country":{"@id":"XI","$":"South East Asia"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2012-02-14T00:00:00Z","SourceLink":{"@type":"PR","@id":"1262668"}},{"Company":{"@id":"1038320","$":"Eczacibasi Ilac Pazarlama AS"},"Country":{"@id":"TR","$":"Turkey"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2017-05-24T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1930536"}},{"Company":{"@id":"14453","$":"Hyland Immuno"},"Country":{"@id":"BE","$":"Belgium"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2003-01-21T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"477062"}},{"Company":{"@id":"14453","$":"Hyland Immuno"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2003-01-21T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"477062"}},{"Company":{"@id":"16074","$":"Laboratorios Dr Esteve SA"},"Country":{"@id":"X5","$":"Europe"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-08-29T00:00:00Z","SourceLink":{"@type":"PR","@id":"1218277"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"CA","$":"Canada"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-12-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884314"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"MX","$":"Mexico"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-12-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884314"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-12-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884314"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"2989","$":"Kidney transplant rejection"},"StatusDate":"2016-12-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884314"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"250","$":"Pancreatitis"},"StatusDate":"2016-12-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884314"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"AT","$":"Austria"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"FR","$":"France"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"DE","$":"Germany"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"GB","$":"UK"},"DevelopmentStatus":{"@id":"DX","@sortorder":"4","$":"Discontinued"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"NDR","@sortorder":"3","$":"No Development Reported"},"Indication":{"@id":"57","$":"Cardiovascular disease"},"StatusDate":"2007-10-26T00:00:00Z"},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"CA","$":"Canada"},"DevelopmentStatus":{"@id":"NDR","@sortorder":"3","$":"No Development Reported"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2018-12-14T00:00:00Z"},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"CN","$":"China"},"DevelopmentStatus":{"@id":"NDR","@sortorder":"3","$":"No Development Reported"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2019-06-21T00:00:00Z"},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"MX","$":"Mexico"},"DevelopmentStatus":{"@id":"NDR","@sortorder":"3","$":"No Development Reported"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2018-06-08T00:00:00Z"},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"NDR","@sortorder":"3","$":"No Development Reported"},"Indication":{"@id":"188","$":"Inflammatory disease"},"StatusDate":"2007-10-26T00:00:00Z"},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"NDR","@sortorder":"3","$":"No Development Reported"},"Indication":{"@id":"1024","$":"Reperfusion injury"},"StatusDate":"2009-05-05T00:00:00Z"},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"NDR","@sortorder":"3","$":"No Development Reported"},"Indication":{"@id":"65","$":"Stroke"},"StatusDate":"2012-07-25T00:00:00Z"},{"Company":{"@id":"1010384","$":"Shanghai Institute of Pharmaceutical Industry"},"Country":{"@id":"CN","$":"China"},"DevelopmentStatus":{"@id":"NDR","@sortorder":"3","$":"No Development Reported"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2019-06-21T00:00:00Z"},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"OL","@sortorder":"1","$":"Outlicensed"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2012-03-26T00:00:00Z","SourceLink":{"@type":"PR","@id":"1274358"}}]},"DevelopmentStatusHistoric":{"Row":[{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-11-03T00:00:00Z","SourceLink":{"@type":"PR","@id":"1607808"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"AT","$":"Austria"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"FR","$":"France"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-08-31T00:00:00Z","SourceLink":{"@type":"PR","@id":"1218545"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"DE","$":"Germany"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-08-31T00:00:00Z","SourceLink":{"@type":"PR","@id":"1218545"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-08-31T00:00:00Z","SourceLink":{"@type":"PR","@id":"1218545"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"GB","$":"UK"},"DevelopmentStatus":{"@id":"L","@sortorder":"15","$":"Launched"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-08-31T00:00:00Z","SourceLink":{"@type":"PR","@id":"1218545"}},{"Company":{"@id":"1068926","$":"Hyupjin Corp"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2015-12-21T00:00:00Z","SourceLink":{"@type":"PR","@id":"1723098"}},{"Company":{"@id":"16074","$":"Laboratorios Dr Esteve SA"},"Country":{"@id":"EU","$":"EU"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-10-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1142983"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"IS","$":"Iceland"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-10-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1142983"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"IL","$":"Israel"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-01-15T00:00:00Z","SourceLink":{"@type":"PR","@id":"1515653"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"LI","$":"Liechtenstein"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-10-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1142983"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NO","$":"Norway"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-10-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1142983"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-07-17T00:00:00Z","SourceLink":{"@type":"PR","@id":"1577947"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-07-17T00:00:00Z","SourceLink":{"@type":"PR","@id":"1577947"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"EU","$":"EU"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-10-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1142983"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"IS","$":"Iceland"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-10-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1142983"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"LI","$":"Liechtenstein"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-10-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1142983"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"NO","$":"Norway"},"DevelopmentStatus":{"@id":"R","@sortorder":"14","$":"Registered"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-10-28T00:00:00Z","SourceLink":{"@type":"PR","@id":"1142983"}},{"Company":{"@id":"16074","$":"Laboratorios Dr Esteve SA"},"Country":{"@id":"EU","$":"EU"},"DevelopmentStatus":{"@id":"PR","@sortorder":"13","$":"Pre-registration"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2006-07-21T00:00:00Z","SourceLink":{"@type":"PR","@id":"679518"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"EU","$":"EU"},"DevelopmentStatus":{"@id":"PR","@sortorder":"13","$":"Pre-registration"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2006-07-21T00:00:00Z","SourceLink":{"@type":"PR","@id":"679518"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"PR","@sortorder":"13","$":"Pre-registration"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2013-04-17T00:00:00Z","SourceLink":{"@type":"PR","@id":"1405049"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"PR","@sortorder":"13","$":"Pre-registration"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-01-02T00:00:00Z","SourceLink":{"@type":"PR","@id":"1512632"}},{"Company":{"@id":"15957","$":"Santarus Inc"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"PR","@sortorder":"13","$":"Pre-registration"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2013-04-17T00:00:00Z","SourceLink":{"@type":"PR","@id":"1405049"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"EU","$":"EU"},"DevelopmentStatus":{"@id":"PR","@sortorder":"13","$":"Pre-registration"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-04-15T00:00:00Z","SourceLink":{"@type":"PR","@id":"1090974"}},{"Company":{"@id":"16074","$":"Laboratorios Dr Esteve SA"},"Country":{"@id":"X5","$":"Europe"},"DevelopmentStatus":{"@id":"C3","@sortorder":"12","$":"Phase 3 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2004-07-07T00:00:00Z","SourceLink":{"@type":"PR","@id":"547967"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"X5","$":"Europe"},"DevelopmentStatus":{"@id":"C3","@sortorder":"12","$":"Phase 3 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2004-07-07T00:00:00Z","SourceLink":{"@type":"PR","@id":"547967"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C3","@sortorder":"12","$":"Phase 3 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2005-05-06T00:00:00Z","SourceLink":{"@type":"PR","@id":"599963"}},{"Company":{"@id":"15957","$":"Santarus Inc"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C3","@sortorder":"12","$":"Phase 3 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-02-22T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1269430"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"BE","$":"Belgium"},"DevelopmentStatus":{"@id":"C2","@sortorder":"11","$":"Phase 2 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2003-01-07T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"475585"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"CA","$":"Canada"},"DevelopmentStatus":{"@id":"C2","@sortorder":"11","$":"Phase 2 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2015-01-09T00:00:00Z","SourceLink":{"@type":"PR","@id":"1625306"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C2","@sortorder":"11","$":"Phase 2 Clinical"},"Indication":{"@id":"2989","$":"Kidney transplant rejection"},"StatusDate":"2010-11-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1146331"}},{"Company":{"@id":"15957","$":"Santarus Inc"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C2","@sortorder":"11","$":"Phase 2 Clinical"},"Indication":{"@id":"2989","$":"Kidney transplant rejection"},"StatusDate":"2010-11-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1146331"}},{"Company":{"@id":"14453","$":"Hyland Immuno"},"Country":{"@id":"BE","$":"Belgium"},"DevelopmentStatus":{"@id":"C1","@sortorder":"10","$":"Phase 1 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2001-03-12T00:00:00Z","SourceLink":{"@type":"PR","@id":"401486"}},{"Company":{"@id":"14453","$":"Hyland Immuno"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C1","@sortorder":"10","$":"Phase 1 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2001-03-12T00:00:00Z","SourceLink":{"@type":"PR","@id":"401486"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"BE","$":"Belgium"},"DevelopmentStatus":{"@id":"C1","@sortorder":"10","$":"Phase 1 Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2001-03-12T00:00:00Z","SourceLink":{"@type":"PR","@id":"401486"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C1","@sortorder":"10","$":"Phase 1 Clinical"},"Indication":{"@id":"250","$":"Pancreatitis"},"StatusDate":"2014-01-02T00:00:00Z","SourceLink":{"@type":"PR","@id":"1512632"}},{"Company":{"@id":"15957","$":"Santarus Inc"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"C1","@sortorder":"10","$":"Phase 1 Clinical"},"Indication":{"@id":"250","$":"Pancreatitis"},"StatusDate":"2013-04-11T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"1434839"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"CU","@sortorder":"9","$":"Clinical"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2005-03-09T00:00:00Z","SourceLink":{"@type":"PR","@id":"588950"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"AR","$":"Argentina"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-02-09T00:00:00Z","SourceLink":{"@type":"PR","@id":"1734288"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"CO","$":"Colombia"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2015-05-25T00:00:00Z","SourceLink":{"@type":"PR","@id":"1663014"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"CR","$":"Costa Rica"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-02-09T00:00:00Z","SourceLink":{"@type":"PR","@id":"1734288"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"DO","$":"Dominican Republic"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-02-09T00:00:00Z","SourceLink":{"@type":"PR","@id":"1734288"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"PA","$":"Panama"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-02-09T00:00:00Z","SourceLink":{"@type":"PR","@id":"1734288"}},{"Company":{"@id":"1109567","$":"Cytobioteck"},"Country":{"@id":"VE","$":"Venezuela"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2015-05-25T00:00:00Z","SourceLink":{"@type":"PR","@id":"1663014"}},{"Company":{"@id":"1038320","$":"Eczacibasi Ilac Pazarlama AS"},"Country":{"@id":"TR","$":"Turkey"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2008-03-25T00:00:00Z","SourceLink":{"@type":"PR","@id":"889010"}},{"Company":{"@id":"14453","$":"Hyland Immuno"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2000-03-22T00:00:00Z","SourceLink":{"@type":"PR","@id":"360393"}},{"Company":{"@id":"1068926","$":"Hyupjin Corp"},"Country":{"@id":"KR","$":"South Korea"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2012-03-26T00:00:00Z","SourceLink":{"@type":"PR","@id":"1274358"}},{"Company":{"@id":"16074","$":"Laboratorios Dr Esteve SA"},"Country":{"@id":"ES","$":"Spain"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2004-06-30T00:00:00Z","SourceLink":{"@type":"PR","@id":"547967"}},{"Company":{"@id":"26786","$":"MegaPharm Ltd"},"Country":{"@id":"IL","$":"Israel"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2011-06-07T00:00:00Z","SourceLink":{"@type":"PR","@id":"1197987"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"57","$":"Cardiovascular disease"},"StatusDate":"2005-02-24T00:00:00Z","SourceLink":{"@type":"PR","@id":"586887"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"DZ","$":"Algeria"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"AD","$":"Andorra"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"BH","$":"Bahrain"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"BE","$":"Belgium"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"1999-03-19T17:05:40Z","SourceLink":{"@type":"PR","@id":"317961"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"CN","$":"China"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-12-30T00:00:00Z","SourceLink":{"@type":"OTHER","@id":"1623768"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"IE","$":"Ireland"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"JO","$":"Jordan"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"KW","$":"Kuwait"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"LB","$":"Lebanon"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"LU","$":"Luxembourg"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"MX","$":"Mexico"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-12-08T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884314"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"MA","$":"Morocco"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2007-11-05T00:00:00Z","SourceLink":{"@type":"OTHER","@id":"848209"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"OM","$":"Oman"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"PT","$":"Portugal"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"QA","$":"Qatar"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"ES","$":"Spain"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"CH","$":"Switzerland"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"SY","$":"Syria"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"TN","$":"Tunisia"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"AE","$":"United Arab Emirates"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"YE","$":"Yemen"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2016-10-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1884970"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"188","$":"Inflammatory disease"},"StatusDate":"2005-02-24T00:00:00Z","SourceLink":{"@type":"PR","@id":"586887"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"2989","$":"Kidney transplant rejection"},"StatusDate":"2008-09-03T00:00:00Z","SourceLink":{"@type":"PR","@id":"939943"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"BE","$":"Belgium"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"1259","$":"Pre-eclampsia"},"StatusDate":"2018-07-26T00:00:00Z","SourceLink":{"@type":"PR","@id":"2057258"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"1259","$":"Pre-eclampsia"},"StatusDate":"2018-09-30T00:00:00Z","SourceLink":{"@type":"PR","@id":"2161502"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"1024","$":"Reperfusion injury"},"StatusDate":"2007-11-05T00:00:00Z","SourceLink":{"@type":"OTHER","@id":"848209"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"NL","$":"Netherlands"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"65","$":"Stroke"},"StatusDate":"2007-11-05T00:00:00Z","SourceLink":{"@type":"OTHER","@id":"848209"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"CA","$":"Canada"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-01-02T00:00:00Z","SourceLink":{"@type":"PR","@id":"1512632"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"MX","$":"Mexico"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-01-02T00:00:00Z","SourceLink":{"@type":"PR","@id":"1512632"}},{"Company":{"@id":"24643","$":"Salix Pharmaceuticals Ltd"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"2989","$":"Kidney transplant rejection"},"StatusDate":"2014-01-02T00:00:00Z","SourceLink":{"@type":"PR","@id":"1512632"}},{"Company":{"@id":"15957","$":"Santarus Inc"},"Country":{"@id":"CA","$":"Canada"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-09-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1130308"}},{"Company":{"@id":"15957","$":"Santarus Inc"},"Country":{"@id":"MX","$":"Mexico"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-09-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1130308"}},{"Company":{"@id":"15957","$":"Santarus Inc"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2010-09-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1130308"}},{"Company":{"@id":"15957","$":"Santarus Inc"},"Country":{"@id":"US","$":"US"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"2989","$":"Kidney transplant rejection"},"StatusDate":"2010-09-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1130308"}},{"Company":{"@id":"1010384","$":"Shanghai Institute of Pharmaceutical Industry"},"Country":{"@id":"CN","$":"China"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2013-07-01T00:00:00Z","SourceLink":{"@type":"PR","@id":"1446251"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"AZ","$":"Azerbaijan"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"BY","$":"Belarus"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"GE","$":"Georgia"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"KZ","$":"Kazakhstan"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"RU","$":"Russian Federation"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"RS","$":"Serbia"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"28921","$":"Swedish Orphan Biovitrum AB"},"Country":{"@id":"UA","$":"Ukraine"},"DevelopmentStatus":{"@id":"DR","@sortorder":"7","$":"Discovery"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2014-10-13T00:00:00Z","SourceLink":{"@type":"PR","@id":"1696826"}},{"Company":{"@id":"26342","$":"Pharming NV"},"Country":{"@id":"BE","$":"Belgium"},"DevelopmentStatus":{"@id":"S","@sortorder":"6","$":"Suspended"},"Indication":{"@id":"156","$":"Hereditary angioedema"},"StatusDate":"2001-08-30T00:00:00Z","SourceLink":{"@type":"CORPORATE","@id":"420400"}}]}}}}